Related references
Note: Only part of the references are listed.Shape-engineered vascular endothelial cells: Nitric oxide production, cell elasticity, and actin cytoskeletal features
Satoru Kidoaki et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2007)
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
S. Bianchi et al.
KIDNEY INTERNATIONAL (2006)
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
K. J. Schjoedt et al.
KIDNEY INTERNATIONAL (2006)
Aldosterone-induced inflammation in the rat heart - Role of oxidative stress
Y Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Aldosterone induces a vascular inflammatory phenotype in the rat heart
R Rocha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Aldosterone induces acute endothelial dysfunction in vivo in humans:: evidence for an aldosterone-induced vasculopathy
CAJ Farquharson et al.
CLINICAL SCIENCE (2002)
Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response
RA Beswick et al.
HYPERTENSION (2001)
Cyclic stretching of mesangial cells up-regulates intercellular adhesion molecule-1 and leukocyte adherence - A possible new mechanism for glomerulosclerosis
BL Riser et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Local angiotensin II and transforming growth factor-β1 in renal fibrosis of rats
Y Sun et al.
HYPERTENSION (2000)
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure
CAJ Farquharson et al.
CIRCULATION (2000)
Share Paper
